These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 14751076)

  • 1. [Resistance mechanisms to Methotrexate].
    Jin M; Wu MY
    Zhonghua Er Ke Za Zhi; 2003 May; 41(5):388-90. PubMed ID: 14751076
    [No Abstract]   [Full Text] [Related]  

  • 2. Polymorphisms in methylenetetrahydrofolate reductase and methotrexate sensitivity in childhood acute lymphoblastic leukemia.
    Taub JW; Matherly LH; Ravindranath Y; Kaspers GJ; Rots MG; Zantwijk CH
    Leukemia; 2002 Apr; 16(4):764-5. PubMed ID: 11960366
    [No Abstract]   [Full Text] [Related]  

  • 3. Infants with acute lymphoblastic leukemia: no evidence for high methotrexate resistance.
    Ramakers-van Woerden NL; Pieters R; Rots MG; van Zantwijk CH; Noordhuis P; Beverloo HB; Peters GJ; van Wering ER; Camitta BM; Pui CH; Relling MV; Evans WE; Veerman AJ
    Leukemia; 2002 May; 16(5):949-51. PubMed ID: 11986959
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene expression profiling of leukemia T-cells resistant to methotrexate and 7-hydroxymethotrexate reveals alterations that preserve intracellular levels of folate and nucleotide biosynthesis.
    Fotoohi AK; Assaraf YG; Moshfegh A; Hashemi J; Jansen G; Peters GJ; Larsson C; Albertioni F
    Biochem Pharmacol; 2009 Apr; 77(8):1410-7. PubMed ID: 19426680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing antimetabolite-based chemotherapy for the treatment of childhood acute lymphoblastic leukaemia.
    Estlin EJ; Lowis SP; Hall AG
    Br J Haematol; 2000 Jul; 110(1):29-40. PubMed ID: 10930977
    [No Abstract]   [Full Text] [Related]  

  • 6. Reduced folate carrier mutations are not the mechanism underlying methotrexate resistance in childhood acute lymphoblastic leukemia.
    Kaufman Y; Drori S; Cole PD; Kamen BA; Sirota J; Ifergan I; Arush MW; Elhasid R; Sahar D; Kaspers GJ; Jansen G; Matherly LH; Rechavi G; Toren A; Assaraf YG
    Cancer; 2004 Feb; 100(4):773-82. PubMed ID: 14770434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced elimination of Methotrexate in an adult with trisomy 21 and acute lymphoblastic leukaemia.
    Thachil J
    Leuk Res; 2007 Oct; 31(10):1452-3. PubMed ID: 17178159
    [No Abstract]   [Full Text] [Related]  

  • 8. Methotrexate inhibits the glyoxalase system in vivo in children with acute lymphoid leukaemia.
    Bartyik K; Turi S; Orosz F; Karg E
    Eur J Cancer; 2004 Oct; 40(15):2287-92. PubMed ID: 15454255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo activity of methotrexate versus novel antifolate inhibitors of dihydrofolate reductase and thymidylate synthase against childhood leukemia cells.
    Mauritz R; Bekkenk MW; Rots MG; Pieters R; Mini E; van Zantwijk CH; Veerman AJ; Peters GJ; Jansen G
    Clin Cancer Res; 1998 Oct; 4(10):2399-410. PubMed ID: 9796971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Czech children with acute lymphoblastic leukemia: a report of the Czech Working Group for Pediatric Hematology.
    Starý J; Gajdos P; Hrstková H; Blazek B; Slavík Z; Mihál V; Zahálka F; Jabali Y; Vávra V; Kopecná L; Mydlil J; Trka J
    Med Pediatr Oncol; 2002 Aug; 39(2):125-7. PubMed ID: 12116061
    [No Abstract]   [Full Text] [Related]  

  • 11. Towards personalized medicine - the role of methotrexate.
    Naik S
    Indian J Med Res; 2011 Mar; 133(3):253-5. PubMed ID: 21441677
    [No Abstract]   [Full Text] [Related]  

  • 12. HSH2D contributes to methotrexate resistance in human T‑cell acute lymphoblastic leukaemia.
    Wang J; Xiong Y
    Oncol Rep; 2020 Nov; 44(5):2121-2129. PubMed ID: 33000278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated achilles tendinitis after high dose methotrexate.
    Toverud EL; Landaas S; Hellebostad M
    Med Pediatr Oncol; 2001 Aug; 37(2):156. PubMed ID: 11496361
    [No Abstract]   [Full Text] [Related]  

  • 14. [Methotrexate resistance in acute leukemias].
    Styczyński J; Wysocki M
    Pol Merkur Lekarski; 2001 Aug; 11(62):175-9. PubMed ID: 11757224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed elimination of methotrexate in a patient receiving ciprofloxacin.
    Aouinti I; Gaïes E; Trabelsi S; Salouage I; Jebabli N; Charfi R; Lakhal M; Klouz A
    Therapie; 2013; 68(3):175-7. PubMed ID: 23886465
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence for negative feedback of extracellular methotrexate on blasts of acute lymphoblastic leukemia in vitro.
    Hum MC; Smith AK; Lark RH; Winick NJ; Kamen BA
    Pharmacotherapy; 1997; 17(6):1260-6. PubMed ID: 9399609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does pharmacokinetic variability influence the efficacy of high-dose methotrexate for the treatment of children with acute lymphoblastic leukemia: what can we learn from small studies?
    Evans WE; Relling MV; Boyett JM; Pui CH
    Leuk Res; 1997 May; 21(5):435-7. PubMed ID: 9225072
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic polymorphisms of folate metabolic enzymes and toxicities of high dose methotrexate in children with acute lymphoblastic leukemia.
    Pakakasama S; Kanchanakamhaeng K; Kajanachumpol S; Udomsubpayakul U; Sirachainan N; Thithapandha A; Hongeng S
    Ann Hematol; 2007 Aug; 86(8):609-11. PubMed ID: 17323057
    [No Abstract]   [Full Text] [Related]  

  • 19. High-dose methotrexate is lethal to rats. Why give it to children?
    Cole PD; Kamen BA
    Pediatr Hematol Oncol; 2000 Dec; 17(8):609-13. PubMed ID: 11127392
    [No Abstract]   [Full Text] [Related]  

  • 20. Methotrexate-related neurotoxicity in the treatment of childhood acute lymphoblastic leukemia.
    Shuper A; Stark B; Kornreich L; Cohen IJ; Avrahami G; Yaniv I
    Isr Med Assoc J; 2002 Nov; 4(11):1050-3. PubMed ID: 12489505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.